Advisory Services Network’s Celldex Therapeutics CLDX Stock Holding History

Advisory Services Network’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,625	Closed	-$147K	–	2608
2026 Q1	$147K	Buy	+4,625	New	+$126K	﹤0.01%	1988
2025 Q4	–	Sell	-5,390	Closed	-$139K	–	2253
2025 Q3	$139K	Buy	+5,390	New	+$125K	﹤0.01%	1884
2023 Q2	–	Sell	-200	Closed	-$7.2K	–	1844
2023 Q1	$7.2K	Hold	200	–	–	﹤0.01%	3006
2022 Q4	$8.91K	Buy	+200	New	+$7.14K	﹤0.01%	2907
2021 Q3	–	Sell	-17	Closed	-$1K	–	1723
2021 Q2	$1K	Buy	+17	New	+$467	﹤0.01%	3431
2021 Q1	–	Sell	-17	Closed	–	–	1570
2020 Q4	$0	Hold	17	–	–	﹤0.01%	3356
2020 Q3	$0	Buy	+17	New	+$199	﹤0.01%	3554
2020 Q2	–	Sell	-17	Closed	–	–	1317
2020 Q1	$0	Hold	17	–	–	﹤0.01%	3061
2019 Q4	$0	Hold	17	–	–	﹤0.01%	3100
2019 Q3	$0	Hold	17	–	–	﹤0.01%	2804
2019 Q2	$0	Hold	17	–	–	﹤0.01%	2815
2019 Q1	$0	Sell	17 -1	-6%	-$5	﹤0.01%	2542
2018 Q4	$0	Buy	18 +1	+6%	+$5	﹤0.01%	2538
2018 Q3	$0	Hold	17	–	–	﹤0.01%	2507
2018 Q2	$0	Hold	17	–	–	﹤0.01%	2490
2018 Q1	$1K	Hold	17	–	–	﹤0.01%	2452
2017 Q4	$1K	Hold	17	–	–	﹤0.01%	2432
2017 Q3	$1K	Hold	17	–	–	﹤0.01%	2255
2017 Q2	$1K	Hold	17	–	–	﹤0.01%	2202
2017 Q1	$1K	Buy	+17	New	+$885	﹤0.01%	2061
2016 Q2	–	Sell	-6	Closed	–	–	1843
2016 Q1	$0	Hold	6	–	–	﹤0.01%	1684
2015 Q4	$1K	Hold	6	–	–	﹤0.01%	1417
2015 Q3	$1K	Buy	+6	New	+$1.7K	﹤0.01%	1402

Other funds holding CLDX

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's CLDX Position: Q2 2026 in Review

Advisory Services Network sold out of Celldex Therapeutics (CLDX) in Q2 2026, closing a stake of 4,625 shares — an estimated $147K sold.

Advisory Services Network first reported a position in CLDX in Q3 2015 and held it in 23 quarters. The position peaked at $147K in Q1 2026. 253 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.

Advisory Services Network reported no remaining Celldex Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 4,625 Celldex Therapeutics shares in Q2 2026, an estimated $147K.
Advisory Services Network first reported a position in Celldex Therapeutics in Q3 2015 and held it in 23 quarters.
Advisory Services Network's Celldex Therapeutics position peaked at $147K in Q1 2026.
253 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.